Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled “SIRT6 Variant for NASH,” has been published in the European Patent Bulletin.
Publication of the patent application in the European Patent Bulletin follows entry into the European phase under the Patent Cooperation Treaty and represents a key milestone in Genflow’s expanding intellectual property portfolio.
Dec. 08, 2025 12:02 PM ETCarvana Co. (CVNA) Stock, GVIP, TCHP, ONLN, CLIXIBUY, UPGD, PDP, PEZ, MILN, NUMG, BOUT, EBIZ,...
“We want to re-industrialize the United States. We need to be back in manufacturing,” Huang said recently on theJoe Rogan...
Recently listed edtech player PhysicsWallah reported 62% year-on-year (YoY) growth in its consolidated net profit at Rs 72.3 crore in...
IBM said Monday it's buying data streaming platform Confluent in a deal worth $11 billion that will help bolster the...
Israel’s fiscal deficit narrowed to 4.5% of GDP at the end of November, or NIS 932.5 billion in absolute...
It’s been a crazy few weeks in AI.Granted, it feels like it’s always been a crazy few weeks in AI....
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
